Advertisement

Neonatal Meningitis: Can We Do Better?

  • Paul T. HeathEmail author
  • Ifeanyichukwu O. Okike
  • Clarissa Oeser
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 719)

Abstract

Bacterial meningitis is a serious disease worldwide. The greatest risk of acquiring meningitis is in the neonatal period. Neonatal meningitis is associated with significant mortality and, despite improvements in healthcare over the last two decades; severe neurological sequelae remain common and unchanged. There is an urgent need to identify interventions that may have an impact on clinical outcome. Here we discuss the epidemiology and the current management of neonatal bacterial meningitis with a view to identifying areas for future research.

Keywords

Lumbar Puncture Bacterial Meningitis Invasive Pneumococcal Disease Neonatal Infection Neck Flexion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Goldacre MJ. Acute bacterial meningitis in childhood. Lancet. 1976;1:701.PubMedCrossRefGoogle Scholar
  2. 2.
    de Louvois J, Blackbourn J, Hurley R, Harvey D. Infantile meningitis in England and Wales: a two year study. Arch Dis Child. 1991;66:603–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Hristeva L, Booy R, Bowler I, Wilkinson AR. Prospective surveillance of neonatal meningitis. Arch Dis Child. 1993;69:14–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Holt DE, Halket S, de Louvois J, Harvey D. Neonatal meningitis in England and Wales: 10 years on. Arch Dis Child Fetal Neonatal Ed. 2001;84:F85–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Goldacre MJ. Neonatal meningitis. Postgrad Med J. 1977;53:607–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Persson E, Trollfors B, Brandberg LL, Tessin I. Septicaemia and meningitis in neonates and during early infancy in the Goteborg area of Sweden. Acta Paediatr. 2002;91:1087–92.PubMedCrossRefGoogle Scholar
  7. 7.
    Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J. 2009;28:S3–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Synnott MB, Morse DL, Hall SM. Neonatal meningitis in England and Wales: a review of routine national data. Arch Dis Child. 1994;71:F75–80.PubMedGoogle Scholar
  9. 9.
    Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis. 1990;162:1316–23.PubMedCrossRefGoogle Scholar
  10. 10.
    Francis BM, Gilbert GL. Survey of neonatal meningitis in Australia: 1987–1989. Med J Aust. 1992;156:240–3.PubMedGoogle Scholar
  11. 11.
    Levy C, de La Rocque F, Cohen R. [Epidemiology of pediatric bacterial meningitis in France]. Med Mal Infect. 2009;39:419–31.PubMedCrossRefGoogle Scholar
  12. 12.
    Kalliola S, Vuopio-Varkila J, Takala AK, Eskola J. Neonatal group B streptococcal disease in Finland: a ten-year nationwide study. Pediatr Infect Dis J. 1999;18:806–10.PubMedCrossRefGoogle Scholar
  13. 13.
    Fluegge K, Siedler A, Heinrich B, Schulte-Moenting J, Moennig MJ, Bartels DB, et al. Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany. Pediatrics. 2006;117:e1139–45.PubMedCrossRefGoogle Scholar
  14. 14.
    Neto MT. Group B streptococcal disease in Portuguese infants younger than 90 days. Arch Dis Child Fetal Neonatal Ed. 2008;93:F90–3.PubMedCrossRefGoogle Scholar
  15. 15.
    Heath PGT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet. 2004;363:292–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Mulder CJ, Zanen HC. A study of 280 cases of neonatal meningitis in The Netherlands. J Infect. 1984;9:177–84.PubMedCrossRefGoogle Scholar
  17. 17.
    Franco SM, Cornelius VE, Andrews BF. Long-term outcome of neonatal meningitis. Am J Dis Child. 1992;146:567–71.PubMedGoogle Scholar
  18. 18.
    Bedford H, de Louvois J, Halket S, Peckham C, Hurley R, Harvey D. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ. 2001;323:533–6.PubMedCrossRefGoogle Scholar
  19. 19.
    de Louvois J, Halket S, Harvey D. Neonatal meningitis in England and Wales: sequelae at 5 years of age. Eur J Pediatr. 2005;164:730–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292:2357–65.PubMedCrossRefGoogle Scholar
  21. 21.
    Palazzi D, Klein J, C B. Bacterial sepsis and meningitis. In: Remington JS, Klein J, editors. Infectious Disease of the Fetus and Newborn Infants 6th ed. Philadelphia: Elsevier Saunders; 2006. p. 247–95.CrossRefGoogle Scholar
  22. 22.
    Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367:397–403.PubMedCrossRefGoogle Scholar
  23. 23.
    Holt DE. Neonatal meningitis in England and Wales: 10 years on. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2001;84:85 F-9.CrossRefGoogle Scholar
  24. 24.
    May M. Early onset neonatal meningitis in Australia and New Zealand, 1992–2002. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2005;90:F324-f7.PubMedCrossRefGoogle Scholar
  25. 25.
    Heath PT, Balfour GF, Tighe H, Verlander NQ, Lamagni TL, Efstratiou A. Group B streptococcal disease in infants: a case control study. Archives of Disease in Childhood. 2009;94:674–80.PubMedCrossRefGoogle Scholar
  26. 26.
    Merenstein GB. Neonatal sepsis. Current Opinion in Infectious Diseases. 1992;5:553–7.CrossRefGoogle Scholar
  27. 27.
    Johnson CE, Whitwell JK, Pethe K, Saxena K, Super DM. Term newborns who are at risk for sepsis: are lumbar punctures necessary? Pediatrics. 1997;99:E10.PubMedCrossRefGoogle Scholar
  28. 28.
    Fielkow S, Reuter S, Gotoff SP. Cerebrospinal fluid examination in symptom-free infants with risk factors for infection. J Pediatr. 1991;119:971–3.PubMedCrossRefGoogle Scholar
  29. 29.
    Wiswell TE, Baumgart S, Gannon CM, Spitzer AR. No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed? Pediatrics. 1995;95:803–6.PubMedGoogle Scholar
  30. 30.
    Visser VE, Hall RT. Lumbar puncture in the evaluation of suspected neonatal sepsis. J Pediatr. 1980;96:1063–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Garges HP. Neonatal Meningitis: What Is the Correlation Among Cerebrospinal Fluid Cultures, Blood Cultures, and Cerebrospinal Fluid Parameters? Pediatrics. 2006;117:1094–100.PubMedCrossRefGoogle Scholar
  32. 32.
    Ansong AK, Smith PB, Benjamin DK, Clark RH, Li JS, Cotten CM, et al. Group B streptococcal meningitis: cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis. Early Hum Dev. 2009;85:S5–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Vergnano S, Embleton N, Collinson A, Menson E, Russell BA, Heath P. Missed opportunities for preventing group B streptococcus infection. Archives of Disease in Childhood - Fetal and Neonatal Edition 2009;95:F72–F3.PubMedCrossRefGoogle Scholar
  34. 34.
    Kestenbaum LA, Ebberson J, Zorc JJ, Hodinka RL, Shah SS. Defining Cerebrospinal Fluid White Blood Cell Count Reference Values in Neonates and Young Infants. Pediatrics. 2010;125:257–64.PubMedCrossRefGoogle Scholar
  35. 35.
    Sarman G, Moise AA, Edwards MS. Meningeal inflammation in neonatal gram-negative bacteremia. Pediatr Infect Dis J. 1995;14:701–4.PubMedCrossRefGoogle Scholar
  36. 36.
    Nigrovic LE, Malley R, Macias CG, Kanegaye JT, Moro-Sutherland DM, Schremmer RD, et al. Effect of Antibiotic Pretreatment on Cerebrospinal Fluid Profiles of Children With Bacterial Meningitis. Pediatrics. 2008;122:726–30.PubMedCrossRefGoogle Scholar
  37. 37.
    Chiba N, Murayama SY, Morozumi M, Nakayama E, Okada T, Iwata S, et al. Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR. Journal of Infection and Chemotherapy. 2009;15:92–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Rajesh NT, Dutta S, Prasad R, Narang A. Effect of delay in analysis on neonatal cerebrospinal fluid parameters. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2009;95:F25–F9.PubMedCrossRefGoogle Scholar
  39. 39.
    Abo A, Chen L, Johnston P, Santucci K. Positioning for Lumbar Puncture in Children Evaluated by Bedside Ultrasound. Pediatrics. 2010;125:e1149–e53.PubMedCrossRefGoogle Scholar
  40. 40.
    Heath PT. Neonatal meningitis. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2003;88:173 F–8.CrossRefGoogle Scholar
  41. 41.
    Millar M, Philpott A, Wilks M, Whiley A, Warwick S, Hennessy E, et al. Colonization and persistence of ­antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom. J Clin Microbiol. 2008;46:560–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Tiskumara R, Fakharee SH, Liu CQ, Nuntnarumit P, Lui KM, Hammoud M, et al. Neonatal infections in Asia. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2009;94:F144–F8.PubMedCrossRefGoogle Scholar
  43. 43.
    Mitja O, Pigrau C, Ruiz I, Vidal X, Almirante B, Planes AM, et al. Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study. J Antimicrob Chemother. 2009;64:416–23.PubMedCrossRefGoogle Scholar
  44. 44.
    Klinger G, Chin CN, Beyene J, Perlman M. Predicting the outcome of neonatal bacterial meningitis. Pediatrics. 2000;106:477–82.PubMedCrossRefGoogle Scholar
  45. 45.
    Fernando AM, Heath PT, Menson EN. Antimicrobial policies in the neonatal units of the United Kingdom and Republic of Ireland. J Antimicrob Chemother. 2008;61:743–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the ­treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–77.PubMedCrossRefGoogle Scholar
  47. 47.
    Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric septic shock. JAMA. 1991;266:1242–5.PubMedCrossRefGoogle Scholar
  48. 48.
    Han YY, Carcillo JA, Dragotta MA, Bills DM, Watson RS, Westerman ME, et al. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics. 2003;112:793–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Nau R, Wellmer A, Soto A, Koch K, Schneider O, Schmidt H, et al. Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J Infect Dis. 1999;179:1557–60.PubMedCrossRefGoogle Scholar
  50. 50.
    Grandgirard D, Oberson K, Buhlmann A, Gaumann R, Leib SL. Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis. Antimicrob Agents Chemother. 2010;54:1323–6.PubMedCrossRefGoogle Scholar
  51. 51.
    McCracken GH, Jr., Mize SG. A controlled study of intrathecal antibiotic therapy in gram-negative enteric ­meningitis of infancy. Report of the neonatal meningitis cooperative study group. J Pediatr. 1976;89:66–72.PubMedCrossRefGoogle Scholar
  52. 52.
    McCracken GH, Jr., Mize SG, Threlkeld N. Intraventricular gentamicin therapy in gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Cooperative Study Group. Lancet. 1980;1:787–91.PubMedGoogle Scholar
  53. 53.
    Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev. 2004:CD001239.Google Scholar
  54. 54.
  55. 55.
    Bedford Russell AR, Emmerson AJ, Wilkinson N, Chant T, Sweet DG, Halliday HL, et al. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia. Arch Dis Child Fetal Neonatal Ed. 2001;84:F172–6.PubMedCrossRefGoogle Scholar
  56. 56.
    Carr R, Brocklehurst P, Dore CJ, Modi N. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial. Lancet. 2009;373:226–33.PubMedCrossRefGoogle Scholar
  57. 57.
    Yu JS, Grauaug A. Purulent Meningitis in the Neonatal Period. Arch Dis Child. 1963;38:391–6.PubMedCrossRefGoogle Scholar
  58. 58.
    Daoud AS, Batieha A, Al-Sheyyab M, Abuekteish F, Obeidat A, Mahafza T. Lack of effectiveness of dexamethasone in neonatal bacterial meningitis. Eur J Pediatr. 1999;158:230–3.PubMedCrossRefGoogle Scholar
  59. 59.
    Peltola H, Roine I, Fernandez J, Zavala I, Ayala SG, Mata AG, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-­controlled trial. Clin Infect Dis. 2007;45:1277–86.PubMedCrossRefGoogle Scholar
  60. 60.
    Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine. 2003;21:3468–72.PubMedCrossRefGoogle Scholar
  61. 61.
    Law MR, Palomaki G, Alfirevic Z, Gilbert R, Heath P, McCartney C, et al. The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. J Med Screen. 2005;12:60–8.PubMedCrossRefGoogle Scholar
  62. 62.
    Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA. 2006;295:1668–74.PubMedCrossRefGoogle Scholar
  63. 63.
    Slack M, et al. The 7th International Symposium on Pneumococci and Pneumococcal Diseases. Tel Aviv Israel 2010.Google Scholar
  64. 64.
    Sarff LD, Platt LH, McCracken GH, Jr. Cerebrospinal fluid evaluation in neonates: comparison of high-risk infants with and without meningitis. J Pediatr. 1976;88:473–7.PubMedCrossRefGoogle Scholar
  65. 65.
    Portnoy JM, Olson LC. Normal cerebrospinal fluid values in children: another look. Pediatrics. 1985;75:484–7.PubMedGoogle Scholar
  66. 66.
    Bonadio WA, Stanco L, Bruce R, Barry D, Smith D. Reference values of normal cerebrospinal fluid composition in infants ages 0 to 8 weeks. Pediatr Infect Dis J. 1992;11:589–91.PubMedGoogle Scholar
  67. 67.
    Ahmed A, Hickey SM, Ehrett S, Trujillo M, Brito F, Goto C, et al. Cerebrospinal fluid values in the term neonate. Pediatr Infect Dis J. 1996;15:298–303.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Paul T. Heath
    • 1
    Email author
  • Ifeanyichukwu O. Okike
    • 1
  • Clarissa Oeser
    • 1
  1. 1.Child Health and Vaccine Institute, St GeorgesUniversity of LondonLondonUK

Personalised recommendations